Reports

357 Results (Page 15 of 15)

Malaysia Markets Research Reports

Medical Devices

Malaysia Dental Consumables Market Analysis

The Malaysia Dental Consumables Market was valued at $54.3 Mn in 2023 and is projected to grow at a CAGR of 8.2% from 2023 to 2023, to $94.3 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, and changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Osstem Implant, Danaher, TPC Advanced Technology, GC Corporation, 3M among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Malaysia Patient Adherence Programs Market Analysis

The Malaysia Patient Adherence Programs Market was valued at $20.8 Mn in 2023 and is predicted to grow at a CAGR of 18.2% from 2023 to 2030, to $67.1 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and technological innovations. The prominent players in the Malaysia Patient Adherence Programs Market are Pharmaniaga, Duopharma Biotech, Apex Healthcare Berhad, GSK, and Merck, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia LASIK Surgery Market Analysis

Malaysia LASIK Surgery Market was valued at $5.68 Mn in 2023 and is predicted to grow at a CAGR of 5.41% from 2023 to 2030, to $8.21 Mn by 2030. The key drivers of this industry include the rising prevalence of vision problems, growing economy and disposable income, and medical tourism. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Digital Health

Malaysia Medical Digital Imaging System Market Analysis

The Malaysia Medical Digital Imaging System Market was valued at $49.04 Mn in 2023 and is predicted to grow at a CAGR of 8.4% from 2023 to 2030, to $86.24 Mn by 2030. The key drivers of this industry include healthcare expenditure, increasing disease burden, and technological advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Malaysia Hemodialysis Vascular Grafts Market Analysis

Malaysia Hemodialysis Vascular Grafts Market was valued at $0.34 Bn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $0.48 Bn by 2030. The key drivers of this industry include the rising prevalence of chronic kidney disease (CKD) and End-stage kidney disease (ESRD), the aging population, and government initiatives. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Malaysia Breastfeeding Accessories Market Analysis

Malaysia Breastfeeding Accessories Market was valued at $4.04 Mn in 2023 and is predicted to grow at a CAGR of 7.00% from 2023 to 2030, to $6.48 Mn by 2030. The key drivers of this industry include increasing employment of women, growing awareness of breastfeeding benefits, and technological advancements in products. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Central Nervous System (CNS) Therapeutics Market Analysis

The Malaysia Central Nervous System (CNS)Therapeutics Market was valued at $338 Mn in 2022 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $563 Mn by 2030. The key drivers of this industry include the rising prevalence of CNS disorders, supportive government initiatives, and rising disposable income. The industry is primarily dominated by players such as Abbott, Novartis, Merck, Eisai, AstraZeneca, Otsuka, Duopharma, and Pharmaniaga among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

subscribe to our newsletter
up